We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Comtech Telecommunications
CMTL
$51.8M
| $9.7M | 0.07% |
401,306
+26,624
| +7% | +$650K |
|
302
Travel + Leisure Co
TNL
$4.54B
| $9.61M | 0.07% |
161,651
+155,940
| +2,731% | +$9.88M |
|
303
AdvanSix
ASIX
$567M
| $9.58M | 0.06% |
320,719
+26,145
| +9% | +$785K |
|
304
Mercury Insurance
MCY
$5.94B
| $9.53M | 0.06% |
146,730
+16,725
| +13% | +$1.06M |
|
|
PDM
305
Piedmont Realty Trust
PDM
$1.22B
| $9.46M | 0.06% |
512,399
+42,155
| +9% | +$785K |
|
306
HUB Group
HUBG
$3.01B
| $9.45M | 0.06% |
286,404
+213,386
| +292% | +$7.27M |
|
307
Progress Software
PRGS
$1.55B
| $9.38M | 0.06% |
202,809
+8,806
| +5% | +$399K |
|
308
OFG Bancorp
OFG
$2.21B
| $9.36M | 0.06% |
422,923
+28,521
| +7% | +$678K |
|
309
LiveRamp
RAMP
$2.29B
| $9.35M | 0.06% |
199,492
+95,001
| +91% | +$4.57M |
|
310
SunCoke Energy
SXC
$757M
| $9.31M | 0.06% |
1,303,307
+377,026
| +41% | +$2.68M |
|
311
Cartesian Therapeutics
RNAC
$232M
| $9.28M | 0.06% |
74,005
+4,639
| +7% | +$552K |
|
|
TRUE
312
DELISTED
TrueCar
TRUE
| $9.27M | 0.06% |
1,641,137
+153,266
| +10% | +$772K |
|
|
AERI
313
DELISTED
Aerie Pharmaceuticals
AERI
| $9.25M | 0.06% |
577,832
+377,604
| +189% | +$6.48M |
|
314
UMB Financial
UMBF
$10.7B
| $9.23M | 0.06% |
99,241
+4,688
| +5% | +$445K |
|
315
Eagle Bancorp
EGBN
$867M
| $9.18M | 0.06% |
163,743
+11,158
| +7% | +$618K |
|
316
Amkor Technology
AMKR
$16.1B
| $9.15M | 0.06% |
386,622
-574,201
| -60% | -$12.8M |
|
|
CTXS
317
DELISTED
Citrix Systems Inc
CTXS
| $9.15M | 0.06% |
+78,021
| New | +$9.72M |
|
|
ECHO
318
DELISTED
Echo Global Logistics, Inc.
ECHO
| $9.13M | 0.06% |
296,941
+30,038
| +11% | +$991K |
|
319
EQT Corp
EQT
$33.2B
| $9.08M | 0.06% |
407,939
-56,109
| -12% | -$1.13M |
|
|
TBI
320
Trueblue
TBI
$234M
| $9.03M | 0.06% |
321,379
-57,788
| -15% | -$1.54M |
|
321
Clean Harbors
CLH
$16.1B
| $8.99M | 0.06% |
96,487
-152,378
| -61% | -$13.8M |
|
322
Outfront Media
OUT
$5.64B
| $8.96M | 0.06% |
378,744
-120,168
| -24% | -$2.79M |
|
323
CytomX Therapeutics
CTMX
$705M
| $8.95M | 0.06% |
1,413,867
+816,469
| +137% | +$6.36M |
|
324
OneSpan
OSPN
$562M
| $8.81M | 0.06% |
344,831
+22,717
| +7% | +$594K |
|
325
Upbound Group
UPBD
$1.19B
| $8.78M | 0.06% |
165,438
-163,150
| -50% | -$9.47M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.